TrialCirculation2023

Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled Trial.

Scott D Solomon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.